All Posts

Join Our Team at Pihanga Health - Where Work Meets Lifestyle Looking for a change of pace, a breath of fresh mountain air, and a team that genuinely enjoys working together? We might have just the opportunity for you! Pihanga Health is on the lookout for a Nurse Practitioner to join our friendly and supportive team for a 9-12 month parental leave cover. Location perks? We've got plenty: Nestled at the southern end of Lake Tau po, our practice offers more than just a job-i

Team Coach - Respite Mental Health (Registered Nurse) $105,812 + complexity allowance + 5 weeks' AL + 4 paid well-being days HealthNow Payment Card ($250 per year)+ increased KiwiSaver contribution Lead our Nelson-based respite mental health service in a permanent full-time, Monday–Friday leadership role. What we offer | Ngā āhuatanga kei a mātou $105,812 + complexity allowance Increased KiwiSaver contribution 5th week of annual leave (after 12 months) 4 paid wellbeing days

Conflict in the Middle East Suppliers are working closely with Pharmac to reduce any disruption to people in New Zealand. Where issues arise, we will communicate them on our website and through this email. Conflict in the Middle East: Impact on the supply chain New medicine supply notices Candesartan (Candestar) 4 mg tablets Stock is low. An alternative has been listed, it has French labelling. A patient flyer with pictures is available for download. Isosorbide mononitrate

Please see attached: Recent amendments to the Guidance for registered nurse prescribers

Position Title: Practice Nurse (Registered Nurse) Location: Three Rivers Medical, Gisborne (Tūranganui‑a‑Kiwa) Employment Type: Permanent (0.8 – 1.0 FTE) Hours: To be agreed within practice operating hours Vacancies: 1 position available What We Offer A supportive, collaborative general practice environment The opportunity to work in a large VLCA practice serving a diverse, high‑needs community Meaningful work contributing to improved health equity and whānau wellbeing Pr

We are seeking Nurse Practitioner’s for contract roles in both Napier and/or Hastings to provide weekly rounds at aged residential care facilities. Join us in sunny Hawkes Bay where you can make a real difference in the lives of older adults, while enjoying local beaches, Art Deco charm, wineries, and a relaxed lifestyle along the way. You will work closely with onsite nurses and care teams to: Provide excellent clinical care to ARC residents (rest home level care and

Hāwera Hospital Permanent, part-time or full-time role Play a pivotal role in rural health Health New Zealand | Te Whatu Ora is firmly grounded in the principles of Te Tiriti o Waitangi and is committed to building a health system that serves all New Zealanders. About the role Mātanga tapuhi nurse practitioners have advanced education, clinical training and the demonstrated competence and legal authority to practise beyond the level of a registered nurse. In this role, you wi

We are writing to inform you of the following: Discontinuation: Ipratropium bromide nebuliser soln, 250 mcg per ml, 2 ml ampoule (Univent) New listing: Ipratropium bromide nebuliser soln, 0.5mg per 2ml ampoule (Viatris) Ipratropium bromide nebuliser soln, 250 mcg per ml, 2 ml ampoule (Univent) has been discontinued. Remaining Univent stock is being reserved for ambulances. The alternate Section 29 Accord brand currently listed is expected to be depleted by May 2026. A secon

Pharmac has decided to fund two new combination treatments and widen access to ibrutinib for people with chronic lymphocytic leukaemia (CLL) from 1 May 2026.Under this decision: People with CLL will be able to receive venetoclax with ibrutinib or venetoclax with obinutuzumab as first‑line treatments, meaning they can be used as an initial treatment option rather than after other treatments have been tried. Access to ibrutinib will be widened so it can be used on its own as a

I hope you were all able to take a moment to rest and recharge over the long weekend. The start of the year has been a busy one, and I want to acknowledge the work you do every day to support people, families, whānau and communities, and the impact it can have on your own wellbeing.  Today marks an important milestone. We have launched public consultation on the draft Mental Health and Wellbeing Strategy – a ten-year plan to guide our collective efforts to improve mental hea

Pharmac has decided to fund letermovir, a medicine that helps prevent serious viral infection in people with very weak immune systems. From 1 May 2026, letermovir will be funded for people who have had a stem cell transplant, as well as a small number of other people with severe immunosuppression who cannot use other funded antiviral medicines. This decision follows public consultation and strong feedback from clinicians involved in stem cell transplant care, patient groups,

Our latest webinars and podcast for you: Whole of life protection: A focus on adult vaccination WEBINAR 14 April: Nikki Turner on the importance of adult immunisation as part of comprehensive preventive care in primary practice. Register here Redefining insomnia management WEBINAR 21 April: David Cunnington, a specialist sleep physician, will review contemporary insomnia management, including CBT-I, and discuss the role of medications, including lemborexant, a newer agent

Pharmac is now consulting publicly on potential brand changes for medicines included in the 2025/26 annual tender. Consultation on possible brand changes through the annual tender This year, around a third of the over 400 items that were tendered may result in a brand change. We want to ensure that any decisions we make are informed by the experiences and needs of prescribers and the people they care for. Consultation opens on Wednesday 8 April and closes on Monday 4 May. M

Issue 339 - 2 April 2026 Welcome to the fortnightly Health Improvement and Innovation Digest. The Digest has links to key evidence of interest, with access to new content arranged by topic. You can forward this newsletter to others who may be interested in receiving it. They can register and subscribe here . You can also access other recent issues of the digest here. If you have any queries, please email us at library@health.govt.nz If you have any queries, please email us a

We are pleased to announce our decision to widen access to nivolumab and ipilimumab for treatment of resectable melanoma. From 1 May 2026 , nivolumab in combination with ipilimumab will be funded for people with stage 3B to stage 4 melanoma that can be removed with surgery. This decision was informed by consultation feedback from people with melanoma, their whānau, advocacy groups, clinicians and other health sector stakeholders. You can read the full decision here: Decision

This RCT 1 enrolled 437 secondary care patients aged ≥65 years (mean 75) with CHA₂DS₂-VASc scores ≥2 in men and ≥3 in women. Participants were assigned to 6-month (180-day) monitoring, using an Apple smartwatch with photoplethysmography and single-lead ECG functions, or to standard care. Over 6 months, atrial fibrillation (AF) was detected in 21 patients (9.6%) in the intervention group versus 5 (2.3%) in controls. Several asymptomatic AF episodes were identified only in th

Nurse Practitioner Permanent full-time 0.9-1.0 FTE | Salary $142,470-$157,252 depending on experience The Gardens, Manurewa location, with free parking on site Onsite café with discounted coffee, health insurance, boutique 2 nd edition store and more… At Tōtara Hospice, you’re not just a nurse — you’re a purpose-driven clinician making a real impact every day. Imagine starting your morning surrounded by native trees, peaceful gardens, and a calm oasis far from the city rus

Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 27 March 2026. It includes information on: New updates Resolved Supply Issues Supply issue: Dexamfetamine 5 mg tablets There is a supply issue affecting the Noumed brand of dexamfetamine 5 mg tablets. The supplier has advised that stock will be unavailable from April to June 2026. From 1 April, the Aspen brand of dexamfetamine 5 mg tablets will be

Kia ora, Please follow this link to our website for the March 2026 Tender Notification. Ngā mihi, Stefanie Moir | Tender Analyst Te Pātaka Whaioranga | Pharmac | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington | P: 0800 660 050 | www.pharmac.govt.nz

Triple0 is currently working with a modern, newly established practice in Christchurch that's continuing to grow, and they're looking for a Nurse Practitioner to join their supportive, forward-thinking team. While a permanent role is preferred, there's also flexibility with a 6–12 month option—ideal if you're considering relocating or keen to experience a new environment before committing longer term. ✨ What's on offer: Competitive rates Positive, collaborative team cultu